CSI Market
Sign In | Register

Sonoma Pharmaceuticals Inc (SNOA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access SNOA quarterly Cash Flow →
From Sonoma Pharmaceuticals Inc through Mar 31 2022, changes in Mar 31 2026's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
12 Months 		(Mar 31 2025) (Mar 31 2024) (Mar 31 2023) (Mar 31 2022)
Operating Activities
Income0.00
Depreciation & amortization0.14
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.47
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.37
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Non Cash Interest Expense-
Property Plant And Equipment Additions-
Loss Due To Change In Fair Value Of Common Stock-
Common Stock Issued In Connection With Stock Purchase Agreement-
Reclassification Of Derivative Liabilities To Paid In Capital-
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest-
Change In Provision For Discounts Rebates Distributor Fees And Returns-
Noncash Or Part Noncash Acquisition Net Deferred Consideration Current-
Noncash Or Part Noncash Acquisition Net Deferred Consideration Noncurrent-
Noncash Or Part Noncash Acquisition Taxes Payable-
Noncash Or Part Noncash Acquisition Net Deferred Revenue Current-
Increase Decrease In Deferred Consideration Net Of Discount-
Increase Decrease In Withholding Tax Payable0.43
Increase Decrease In Operating Lease Liability-0.17
Increase Decrease In Contract With Customer Liability0.18
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.02
Increase (Decrease) in Other Accounts Payable0.87
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets1.54
Other Working Capital0.75
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-8.10
Discontinued operations0.00
Net Cash flow from Operating Activities-3.93
Investing Activities
Capital Expenditures-0.19
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase Decrease In Deposits-
Payments To Acquire Other Productive Assets Amount-
Increase Decrease In Deposit-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Proceeds from Other Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.19
Financing Activities
Short-term debt Net-0.27
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.47
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.28
Deferred Finance Costs Ownshare Lending Arrangement Issuance Costs Adjustment-
Deferred Offering Costs-
Proceeds From Cash Settlement Liability-
Principal Payments Related To Capital Leases-
Proceeds From Common Stock Liability-
Proceeds From Exercise Of Stock Options And Warrants-
Benefit From Lease Assumed Less Principal Payments On Rou Assets-
Payment On Atm Agreement Offering-
Proceeds From Stock Options And Purchase Warrants Exercised-
Payments On Ppp Loan-
Payments Of Atm Agreement Costs-
Payments For Fractional Shares Related To Reversesplit0.00
Proceeds From Insurance Premiums Financed0.27
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.48
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-4.13
Total Cash Flow-2.98
4 historic quarters locked

Sign in to unlock the full Sonoma Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Sonoma Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001683168-26-004871

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License